La Jolla Institute for Immunology

What we can learn from SARS

Researchers comb through hundreds of studies to find clues to beating COVID-19
22-May-2020 12:55 PM EDT, by La Jolla Institute for Immunology

Newswise — LA JOLLA, CA—Seventeen years ago, another viral outbreak was in the news. People wore masks, many were nervous to fly. This outbreak, known as SARS, was caused by a type of coronavirus we now call SARS-CoV-1. The difference was that SARS-CoV-1 was controlled and the virus is all but extinct. The newspaper headlines became a distant memory.

But research on coronaviruses continued in labs around the world, and those studies have helped inform the fast-paced COVID-19 research today.

“We need solutions right now,” says Sara Landeras-Bueno, Ph.D., a postdoctoral researcher at La Jolla Institute (LJI). “But it’s so challenging to stay up-to-date on all the publications.”

Indeed, researchers today are publishing 50 to 100 studies a day on COVID-19, and not all the studies have been subject to rigorous peer review. To help researchers understand the mountain of new coronavirus data, Ying-Ting Wang, Ph.D., Sara Landeras-Bueno Ph.D., Jose Angel Regla-Nava, Ph.D., and colleagues recently led a review comparing findings from more than 200 COVID-19 studies with immunological and virological findings in previous SARS research. Their summary, published this week in the online edition of Trends in Microbiology, emphasizes the need for better animal models and structural studies for COVID-19 treatment and vaccine development.

Regla-Nava, who has experience studying SARS and MERS, explains that the viruses that cause SARS and COVID-19 are 79 percent identical. This means we could potentially learn a lot from SARS about how long immunity might last against the novel coronavirus, called SARS-CoV-2. Several recent studies have shown that a person exposed to SARS can still have SARS-fighting antibodies for many years after infection. But the actual number of antibodies really declines after two years.

This could mean that vaccines and natural immunity against SARS-CoV-2 may only provide protection for a few years. 

The researchers also looked at structural studies showing where antibodies can attack these viruses. Both viruses have “spike” proteins that protrude from the virus and are exposed to the human immune system.

Can SARS antibodies also attack these spike proteins on the novel coronavirus? “Although most of the proteins in these viruses are similar, they are not exactly the same,” says Landeras-Bueno. “So it was not easy to find antibodies that could neutralize both.”

Regla-Nava believes we’ll have to tweak current mouse models in the effort to develop vaccines that can elicit truly neutralizing antibodies. “It’s really important to have good animal models for these studies,” he says.

In the meantime, the LJI team is hard at work as part of the LJI Coronavirus Task Force. Wang says it remains critical to try to stay up-to-date with breakthroughs worldwide and summarize those findings in a useful way.

“This is what we can do for now to help the scientific community,” says Wang. 

This review was supported by the Ley, Shresta and Saphire labs at LJI. The work was funded by the Bill and Melinda Gates Foundation grant # INV-006133.

Full citation: Ying-Ting Wang, Sara Landeras-Bueno, Li-En Hsieh, Yutaka Terada, Kenneth Kim, Klaus Ley, Sujan Shresta, Erica Ollmann Saphire and  Jose Angel Regla-Nava. Spiking Pandemic Potential: Structural and Immunological aspects of SARS-CoV-2. Trends in Microbiology, 2020. Doi: https://doi.org/10.1016/j.tim.2020.05.012

Read the review: Spiking Pandemic Potential: Structural and Immunological aspects of SARS-CoV-2

About La Jolla Institute for Immunology

The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease.

 

 




Filters close

Showing results

110 of 2552
14-Jul-2020 8:55 AM EDT
Rapid genome sequencing and screening help hospital manage COVID-19 outbreaks
University of Cambridge

Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections.

Newswise: 236709_web.jpg
Released: 14-Jul-2020 3:05 PM EDT
When a pandemic strikes, we still expect an ambulance
Edith Cowan University

Research published today has found that Australians strongly believe paramedics deserve a work environment free from the threat of physical harm, but when it comes to the risk of infectious disease, it's complicated.

Newswise: Story Tips From Johns Hopkins Experts on COVID-19
Released: 14-Jul-2020 12:40 PM EDT
Story Tips From Johns Hopkins Experts on COVID-19
Johns Hopkins Medicine

Sharon Tapp, who worked as a nurse case manager at Veterans Affairs Medical Center in Washington, D.C., started experiencing sudden body weakness, chest pain, a high temperature and headache on March 18. Concerned, she went to her local urgent care center to find out what was wrong. They told her that these symptoms were flu-like, tested her for the coronavirus and told her to quarantine for 14 days. After five days and no difference in the presentation of her symptoms, the urgent care team contacted Sharon, letting her know that she tested positive for coronavirus and recommending that she go to the emergency department. Sharon’s family took her to Johns Hopkins Medicine’s Suburban Hospital. Because her condition worsened while at Suburban, she was transferred to The Johns Hopkins Hospital in Baltimore within 10 days of being admitted to Suburban Hospital.

Released: 14-Jul-2020 12:05 PM EDT
National Glaucoma Research Foundation Survey Reveals Glaucoma Patients’ Experiences and Concerns During COVID-19 Pandemic
Glaucoma Research Foundation

National survey finds appointment delays and cancellations were the greatest cause of concern; waiting for in-person appointments is greatly preferred over telemedicine.

Newswise: Palliative Nursing’s Role During COVID-19 and Beyond
Released: 14-Jul-2020 11:35 AM EDT
Palliative Nursing’s Role During COVID-19 and Beyond
University of Pennsylvania School of Nursing

As a rapid influx of patients overwhelmed health systems during the coronavirus pandemic, palliative nurses played dual roles supporting patients, patient families, and colleagues. Two researchers at the University of Pennsylvania School of Nursing (Penn Nursing) are among those detailing the important role palliative care has in responding during the COVID-19 pandemic and in future public health crises.

Newswise: 237436_web.jpg
Released: 14-Jul-2020 11:20 AM EDT
New study shows SARS-CoV-2 viral load peaks in the early stages of disease
Elsevier

In a retrospective study, investigators from New York University Langone Health found that the quantity of SARS-CoV-2 (viral load) collected from patients in the emergency department is significantly higher in patients with fewer or milder symptoms who did not require hospitalization--the opposite of what might be expected.

Newswise: Hackensack Meridian CDI has Struck a COVID-19 Research Collaboration with Merck
Released: 14-Jul-2020 10:00 AM EDT
Hackensack Meridian CDI has Struck a COVID-19 Research Collaboration with Merck
Hackensack Meridian Health

The CDI will work with Merck to identify candidate treatments for the still-spreading pandemic.

Released: 14-Jul-2020 9:00 AM EDT
COVID-19 pandemic could be learning opportunity for middle-grade students
Binghamton University, State University of New York

Educators could use the COVID-19 outbreak to help middle-schoolers better understand the world, according to new research from faculty at Binghamton University, State University of New York.


Showing results

110 of 2552

close
1.31895